Guardant Health Inc (NASDAQ: GH) kicked off on Monday, up 6.34% from the previous trading day, before settling in for the closing price of $93.02. Over the past 52 weeks, GH has traded in a range of $22.15-$95.88.
Healthcare Sector giant saw their annual sales slid by -33.61% over the last five years. While this was happening, its average annual earnings per share was recorded 13.04%. With a float of $120.39 million, this company’s outstanding shares have now reached $125.01 million.
Guardant Health Inc (GH) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 4.49%, while institutional ownership is 99.30%. The most recent insider transaction that took place on Oct 17 ’25, was worth 7,766. In this transaction Director of this company sold 116 shares at a rate of $66.95, taking the stock ownership to the 7,725 shares. Before that another transaction happened on Oct 17 ’25, when Company’s Director sold 26 for $66.95, making the entire transaction worth $1,741. This insider now owns 18,324 shares in total.
Guardant Health Inc (GH) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.62 earnings per share (EPS), lower than consensus estimate (set at -0.5) by -0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.80% during the next five years compared to -33.61% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Take a look at Guardant Health Inc’s (GH) current performance indicators. Last quarter, stock had a quick ratio of 3.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.21, a number that is poised to hit -0.78 in the next quarter and is forecasted to reach -2.72 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Analysing the last 5-days average volume posted by the [Guardant Health Inc, GH], we can find that recorded value of 4.9 million was better than the volume posted last year of 2.43 million. As of the previous 9 days, the stock’s Stochastic %D was 92.56%.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 99.47%, which indicates a significant increase from 99.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.95 in the past 14 days, which was higher than the 2.53 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $64.86, while its 200-day Moving Average is $50.76. Now, the first resistance to watch is $101.24. This is followed by the second major resistance level at $103.57. The third major resistance level sits at $107.90. If the price goes on to break the first support level at $94.58, it is likely to go to the next support level at $90.25. Should the price break the second support level, the third support level stands at $87.92.
Guardant Health Inc (NASDAQ: GH) Key Stats
The company with the Market Capitalisation of 12.47 billion has total of 126,041K Shares Outstanding. Its annual sales at the moment are 739,020 K in contrast with the sum of -436,370 K annual income. Company’s last quarter sales were recorded 232,090 K and last quarter income was -99,900 K.
